BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26696634)

  • 1. SMILE Is an Insulin-Inducible Transcriptional Corepressor of Hepatic Gluconeogenic Gene Programs.
    Kim MY; Ahn YH
    Diabetes; 2016 Jan; 65(1):14-5. PubMed ID: 26696634
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
    Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
    Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFIL3 is a negative regulator of hepatic gluconeogenesis.
    Kang G; Han HS; Koo SH
    Metabolism; 2017 Dec; 77():13-22. PubMed ID: 29132537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.
    Rhee J; Inoue Y; Yoon JC; Puigserver P; Fan M; Gonzalez FJ; Spiegelman BM
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4012-7. PubMed ID: 12651943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
    Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
    Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
    Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
    Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
    Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
    Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
    Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
    Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATF3 mediates inhibitory effects of ethanol on hepatic gluconeogenesis.
    Tsai WW; Matsumura S; Liu W; Phillips NG; Sonntag T; Hao E; Lee S; Hai T; Montminy M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2699-704. PubMed ID: 25730876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.
    Jitrapakdee S
    Int J Biochem Cell Biol; 2012 Jan; 44(1):33-45. PubMed ID: 22004992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor Prep1 controls hepatic insulin sensitivity and gluconeogenesis by targeting nuclear localization of FOXO1.
    Kulebyakin K; Penkov D; Blasi F; Akopyan Z; Tkachuk V
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):182-188. PubMed ID: 27815072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.
    Inoue H; Ogawa W; Ozaki M; Haga S; Matsumoto M; Furukawa K; Hashimoto N; Kido Y; Mori T; Sakaue H; Teshigawara K; Jin S; Iguchi H; Hiramatsu R; LeRoith D; Takeda K; Akira S; Kasuga M
    Nat Med; 2004 Feb; 10(2):168-74. PubMed ID: 14716305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanin-1 is a key activator for hepatic gluconeogenesis.
    Chen S; Zhang W; Tang C; Tang X; Liu L; Liu C
    Diabetes; 2014 Jun; 63(6):2073-85. PubMed ID: 24550194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell translocation gene-2 increases hepatic gluconeogenesis via induction of CREB.
    Hwang SL; Kwon O; Lee SJ; Roh SS; Kim YD; Choi JH
    Biochem Biophys Res Commun; 2012 Nov; 427(4):801-5. PubMed ID: 23058912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of HNF-4α as a key transcription factor to promote ChREBP expression in response to glucose.
    Meng J; Feng M; Dong W; Zhu Y; Li Y; Zhang P; Wu L; Li M; Lu Y; Chen H; Liu X; Lu Y; Sun H; Tong X
    Sci Rep; 2016 Mar; 6():23944. PubMed ID: 27029511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1alpha is necessary to support gluconeogenesis during liver regeneration.
    Tajima T; Goda N; Fujiki N; Hishiki T; Nishiyama Y; Senoo-Matsuda N; Shimazu M; Soga T; Yoshimura Y; Johnson RS; Suematsu M
    Biochem Biophys Res Commun; 2009 Oct; 387(4):789-94. PubMed ID: 19643083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α.
    Fang Z; Li P; Jia W; Jiang T; Wang Z; Xiang Y
    Int J Mol Med; 2016 Sep; 38(3):845-52. PubMed ID: 27432632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.